|
We asked 40 pharma leaders, compared with 2011, has your company attended more or fewer conferences and exhibitions?
| More |
12% |
Less |
67% |
| About the same |
21% |
 |
|
|
|
|
|
|
|
11 December, 2012
|
| In this Issue |
The Value of Pharma Procurement
Innovative pharmaceutical procurement has struggled to get the necessary mandate and attention from top management. But things may now be turning around, writes Philipp Polterauer ... Read more |
The Clinical Data Transparency Rush — Are You For or Against?
The days of companies assuming their licensing data can be protected by commercial confidentiality are over. Some companies have seen the writing on the wall. GlaxoSmithKline, for example, took unprecedented action in October 2012 by promising to make raw data from all its trials available to independent researchers ... Read more |
What Key Opinion Leaders Really Want from Pharma
Increased scrutiny and new regulation have seen pharma's relationship with key opinion leaders (KOLs) undergo a paradigm shift in recent years. Sales and marketing teams are no longer the preferred point of contact, explains Dr Samuel Dyer of the Medical Science Liaison Society ... Read more |
Companies Trim Social Media Spending, Says Survey
A new survey reveals that while more pharma companies are using social media and mobile platforms to enhance their sales and marketing initiatives, budgets did not reflect an increase in social media spend. Internal alignments are also shifting, with more people citing executive management as the main sponsors of investment in new technology platforms rather than traditional IT departments ... Read more
|
Pharma's Reputation Improves — Except in China!
The pharmaceutical industry's global reputation is on the mend, even if some countries – notably China – are more hostile, according to the latest Ipsos Reputation Snapshot for the Pharmaceutical Sector ... Read more
|
Why Do So Many New Drugs End Up as Launch Failures?
Pharm Exec's new iPad edition eBook, Global Launch in a Post-blockbuster Era, is available for download now ... Read more
|
|
|
|
